'*Sent by Google Scholar Alerts (scholaralerts-noreply@google.com). Created by [fire](https://fire.fundersclub.com/).*\n\n---\n### \n\n### \n\n### [PDF] [Electrocardiographic Risk Stratification in Primary Pr'
[{"title": "Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophy Cardiomyopathy", "link": "https://www.ahajournals.org/doi/abs/10.1161/CIRCGEN.123.004526", "details": "J Arthur Ataam, N Belbachir, I Perea-Gil, V Termglincan\u2026 - Circulation: Genomic and \u2026, 2024", "abstract": "Correspondence to: Antoni Bay\u00e9s-Genis, MD, PhD, Cardiology Service, Germans Trias i Pujol University Hospital, Carretera de Canyet, s/n, 08916 Badalona, Barcelona, Spain, Email abayesgenis@ gmail. com; or Ioannis Karakikes, PhD \u2026"}, {"title": "PO-02-095 MAARS-HCM: MULTI-MODAL ARTIFICIAL INTELLIGENCE (AI) FOR VENTRICULAR ARRHYTHMIA (VA) RISK STRATIFICATION IN HYPERTROPHIC \u2026", "link": "https://www.heartrhythmjournal.com/article/S1547-5271\\(24\\)01200-1/fulltext", "details": "C Lai, M Yin, DM Popescu, DY Lu, E Scherer, M Engels\u2026 - Heart Rhythm, 2024", "abstract": "Background Current clinical guidelines fall short in accurately identifying HCM patients at risk for sudden cardiac death due to VA. Despite established risk factors like clinical history, symptoms, and cardiac imaging results (such as late-gadolinium \u2026"}]
